CYDAR LIMITED

Active Cambridge

Other professional, scientific and technical activities n.e.c.

39 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
C

CYDAR LIMITED

Other professional, scientific and technical activities n.e.c.

Founded 12 Mar 2012 Active Cambridge, England 39 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
Accounts Submitted 24 Jul 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 22 Apr 2025 Next due 6 May 2026 15 days remaining
Net assets £363K £3M 2024 year on year
Total assets £5M £4M 2024 year on year
Total Liabilities £4M £1M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

20 Station Road Cambridge CB1 2JD England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CYDAR LIMITED (07986624), an active life sciences and medical technology company based in Cambridge, England. Incorporated 12 Mar 2012. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£147.21k

Decreased by £3.76M (-96%)

Net Assets

£362.61k

Decreased by £3.12M (-90%)

Total Liabilities

£4.29M

Decreased by £1.04M (-20%)

Turnover

N/A

Employees

39

Decreased by 9 (-19%)

Debt Ratio

92%

Increased by 32 (+53%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 2

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 1Mar 2022Series A
Investor 2Mar 2022Series A
Investor 3Sept 2022Series A

Share Capital

Share Capital

Share allotments and capital structure

45 Allotments 556,725 Shares £384.18m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
7 Oct 202455£317.9£5.78
2 Aug 20243,974£96k£24.17
2 Aug 202414,480£350k£24.171
2 Aug 20241,467£35k£24.172
2 Aug 2024618£15k£24.272

Officers

Officers

1 active 2 resigned
Status
Andrew Daniel WolfsonDirectorBritishEngland5711 Feb 2022Active

Shareholders

Shareholders (255)

Uk Ff Nominees Limited
5.9%
51,966
Pembroke Vct Plc
5.9%
51,921

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Jul 2025AccountsAnnual accounts made up to 2025-03-31
9 Jul 2025IncorporationMemorandum Articles
9 Jul 2025ResolutionResolutions
29 Apr 2025OfficersTermination of John Eric Deanfield as director on 2025-03-28
22 Apr 2025Confirmation StatementConfirmation statement made on 2025-04-22 with updates
24 Jul 2025 Accounts

Annual accounts made up to 2025-03-31

9 Jul 2025 Incorporation

Memorandum Articles

9 Jul 2025 Resolution

Resolutions

29 Apr 2025 Officers

Termination of John Eric Deanfield as director on 2025-03-28

22 Apr 2025 Confirmation Statement

Confirmation statement made on 2025-04-22 with updates

Recent Activity

Latest Activity

Annual accounts made up to 2025-03-31

9 months ago on 24 Jul 2025

Memorandum Articles

9 months ago on 9 Jul 2025

Resolutions

9 months ago on 9 Jul 2025

Termination of John Eric Deanfield as director on 2025-03-28

11 months ago on 29 Apr 2025

Confirmation statement made on 2025-04-22 with updates

12 months ago on 22 Apr 2025